These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6488163)

  • 21. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
    Pallavicini MG; Gray JW; Folstad LJ
    Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vitro model to predict clinical response in adult acute myelogenous leukemia.
    Karp JE; Donehower RC; Burke PJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):172-81. PubMed ID: 3473676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of proliferative and clonogenic tumor cells in multiple myeloma.
    Karp JE; Burke PJ; Saylor PL; Humphrey RL
    Cancer Res; 1984 Sep; 44(9):4197-200. PubMed ID: 6744329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
    Tsuruo T; Iida H; Hori K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 Nov; 41(11 Pt 1):4484-8. PubMed ID: 7306971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
    Momparler RL; Goodman J; Karon M
    Cancer Res; 1975 Oct; 35(10):2853-7. PubMed ID: 50882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors.
    Grant S; Rauscher F; Cadman E
    Cancer Res; 1982 Oct; 42(10):4007-13. PubMed ID: 6955007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells.
    Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
    Cancer Treat Rep; 1985; 69(7-8):851-7. PubMed ID: 4016794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
    Fietkau R; Friede H; Maurer-Schultze B
    Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
    Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
    White JC; Hines LH; Rathmell JP
    Cancer Res; 1985 Jul; 45(7):3070-5. PubMed ID: 4005845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of S-phase-specific agents on granulocyte-macrophage and erythroid progenitor cells obtained from normal individuals and from patients with chronic myelogenous leukemia.
    Kubota K; Preisler HD; Costanzo C
    Cancer Res; 1983 Aug; 43(8):3927-31. PubMed ID: 6574819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA-specific probe.
    Raza A; Spiridonidis C; Ucar K; Mayers G; Bankert R; Preisler HD
    Cancer Res; 1985 May; 45(5):2283-7. PubMed ID: 3986772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate.
    Edelstein M; Vietti T; Valeriote F
    Cancer Res; 1975 Jun; 35(6):1555-8. PubMed ID: 1131822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic effects of 1-beta-D-arabinofuranosylcytosine and 6-thioguanine in vitro on granulocytic progenitor cells.
    Greenberg PL; VanKersen I; Mosny S
    Cancer Res; 1976 Dec; 36(12):4412-7. PubMed ID: 1069606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts.
    Snyder RD; Malick NC
    Mol Pharmacol; 1985 Dec; 28(6):574-80. PubMed ID: 4079913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
    de Vries JF; Falkenburg JH; Willemze R; Barge RM
    Haematologica; 2006 Jul; 91(7):912-9. PubMed ID: 16818278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.